Vaccine Administration Risk in Guillain-Barré Syndrome: A Systematic Review
DOI:
10.29303/jbt.v25i4.10361Published:
2025-10-23Downloads
Abstract
Guillain-Barré syndrome (GBS) is a disorder in which the body's immune system attacks the peripheral nervous system due to molecular mimicry, characterized by progressive muscle weakness from distal to proximal. This systematic review examines the relationship between vaccination and the risk of GBS. Epidemiological data indicate that the incidence of GBS after vaccination is very low. Although there is a link between vaccination and GBS in some cases, the risk remains smaller than the risk of GBS due to natural infection with the pathogen. This study emphasizes that the benefits of vaccination in preventing infection outweigh the risk of vaccination causing GBS. Guillain-Barré syndrome (GBS) is a disorder in which the body's immune system attacks the peripheral nervous system due to molecular mimicry, causing muscle weakness that progresses rapidly to paralysis. From this literature review, it can be concluded that the risk of GBS after vaccination is very low and is limited to certain vaccines. Furthermore, GBS cases occur more frequently after viral or bacterial infections than after vaccination, indicating that the benefits of vaccination in preventing infectious diseases far outweigh the risk of causing GBS.
Keywords:
Autoimmunity Guillain-Barré syndrome Molecular mimicry Vaccine risk VaccinationReferences
Abara, W. E., Gee, J., Marquez, P., Woo, J., Myers, T. R., Desantis, A., Baumblatt, J. A. G., Woo, E. J., Thompson, D., Nair, N., Su, J. R., Shimabukuro, T. T., & Shay, D. K. (2023). Reports of Guillain-Barré syndrome After COVID-19 Vaccination in the United States. JAMA Network Open, 6(2), 1–14. https://doi.org/10.1001/jamanetworkopen.2022.53845
Abuawwad, M. T., Taha, M. J. J., Taha, A. J., Kozaa, Y. A., Falah, O., Abuawwad, I. T., Hammad, E. M., Mahmoud, A. A., Aladawi, M., & Serhan, H. A. (2024). Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports. Clinical Neurology and Neurosurgery, 238(March 2023), 108183. https://doi.org/10.1016/j.clineuro.2024.108183
Al-Saffar, A., & Al-Fatly, B. (2018). Acute motor axonal neuropathy in association with hepatitis E. Frontiers in Neurology, 9(FEB), 7–10. https://doi.org/10.3389/fneur.2018.00062
Auger, N., Quach, C., Healy-Profitós, J., Dinh, T., & Chassé, M. (2018). Early predictors of Guillain-Barré syndrome in the life course of women. International Journal of Epidemiology, 47(1), 280–288. https://doi.org/10.1093/ije/dyx181
Babazadeh, A., Mohseni Afshar, Z., Javanian, M., Mohammadnia-Afrouzi, M., Karkhah, A., Masrour-Roudsari, J., Sabbagh, P., Koppolu, V., Vasigala, V. K., & Ebrahimpour, S. (2020). Influenza vaccination and Guillain-Barré syndrome: Reality or fear. Journal of Translational Internal Medicine, 7(4), 137–142. https://doi.org/10.2478/jtim-2019-0028
Baxter, R., Lewis, N., Bakshi, N., Vellozzi, C., & Klein, N. P. (2012). Recurrent Guillain-Barré syndrome following vaccination. Clinical Infectious Diseases, 54(6), 800–804. https://doi.org/10.1093/cid/cir960
Bayu, H. T., Demilie, A. E., Molla, M. T., Kumie, F. T., & Endeshaw, A. S. (2024). Mortality and its predictors among patients with Guillain–Barré syndrome in the intensive care unit of a low-income country, Ethiopia: a multicenter retrospective cohort study. Frontiers in Neurology, 15(October), 1–7. https://doi.org/10.3389/fneur.2024.1484661
Bellanti, R., & Rinaldi, S. (2024). Guillain-Barré syndrome: a comprehensive review. European Journal of Neurology, 31(8), 1–15. https://doi.org/10.1111/ene.16365
Bellucci, M., Germano, F., Grisanti, S., Castellano, C., Tazza, F., Mobilia, E. M., Visigalli, D., Novi, G., Massa, F., Rossi, S., Durando, P., Cabona, C., Schenone, A., Franciotta, D., & Benedetti, L. (2022). Case Report: Post-COVID-19 Vaccine Recurrence of Guillain–Barré Syndrome Following an Antecedent Parainfectious COVID-19–Related GBS. Frontiers in Immunology, 13(July), 1–5. https://doi.org/10.3389/fimmu.2022.894872
Boender, T. S., Bartmeyer, B., Coole, L., Wichmann, O., & Harder, T. (2022). Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: A systematic review and meta-analysis, 1 January 2000 to 4 April 2020. Eurosurveillance, 27(4). https://doi.org/10.2807/1560-7917.ES.2022.27.4.2001619
Bragazzi, N. L., Kolahi, A. A., Nejadghaderi, S. A., Lochner, P., Brigo, F., Naldi, A., Lanteri, P., Garbarino, S., Sullman, M. J. M., Dai, H., Wu, J., Kong, J. D., Jahrami, H., Sohrabi, M. R., & Safiri, S. (2021). Global, regional, and national burden of Guillain–Barré syndrome and its underlying causes from 1990 to 2019. Journal of Neuroinflammation, 18(1), 1–12. https://doi.org/10.1186/s12974-021-02319-4
Di Pasquale, A., Preiss, S., Da Silva, F. T., & Garçon, N. (2015). Vaccine adjuvants: From 1920 to 2015 and beyond. Vaccines, 3(2), 320–343. https://doi.org/10.3390/vaccines3020320
Dieleman, J., Romio, S., Johansen, K., Weibel, D., Bonhoeffer, J., & Sturkenboom, M. (2011). Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe. Bmj, 343(7815), 1–13. https://doi.org/10.1136/bmj.d3908
Dodd, C. N., Romio, S. A., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Crawford, N., Deceuninck, G., de Vries, C., De Wals, P., Gimeno, M. V. G., Heijbel, H., Hughes, H., Hur, K., Hviid, A., … Zhang, R. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448–4458. https://doi.org/10.1016/j.vaccine.2013.06.032
Elwood, J. M., & Ameratunga, R. (2018). Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to ‘autoimmune/autoinflammatory syndrome induced by adjuvants’ (ASIA). Vaccine, 36(38), 5796–5802. https://doi.org/10.1016/j.vaccine.2018.07.074
Fadrique, R. S., Arias, L. M., Molina-Guarneros, J. A., Bulnes, N. J., & Ortega, P. G. (2019). Guillain-Barré syndrome and influenza vaccines: Current evidence. Revista Espanola de Quimioterapia, 32(4), 288–295.
Felten, D. L., O’Banion, M. K., Maida, M. S., & Netter, F. H. (2016). Netter’s Atlas of Neuroscience (3rd ed.). Elsevier.
Filosto, M., Cotti Piccinelli, S., Gazzina, S., Foresti, C., Frigeni, B., Servalli, M. C., Sessa, M., Cosentino, G., Marchioni, E., Ravaglia, S., Briani, C., Castellani, F., Zara, G., Bianchi, F., Del Carro, U., Fazio, R., Filippi, M., Magni, E., Natalini, G., … Uncini, A. (2022). Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study. European Journal of Neurology, 29(11), 3358–3367. https://doi.org/10.1111/ene.15497
Frontera, J. A., Tamborska, A. A., Doheim, M. F., Garcia-Azorin, D., Gezegen, H., Guekht, A., Yusof Khan, A. H. K., Santacatterina, M., Sejvar, J., Thakur, K. T., Westenberg, E., Winkler, A. S., Beghi, E., Allegri, R., Baykan, B., Blinc, L., Boruah, A., Bresjanac, M., Bryzgalova, Y., … Zinchuk, M. (2022). Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System. In Annals of Neurology (Vol. 91, Issue 6, pp. 756–771). https://doi.org/10.1002/ana.26339
Gagarkin, D. A., Dombrowski, K. E., Thakar, K. B., & DePetrillo, J. C. (2021). Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report. Journal of Medical Case Reports, 15(1), 1–4. https://doi.org/10.1186/s13256-021-02831-4
García-Grimshaw, M., Michel-Chavez, A., Vera-Zertuche, J. M., Galnares-Olalde, J. A., Hernandez-Vanegas, L. E., Figueroa-Cucurachi, M., Paredes-Ceballos, O., Reyes-Teran, G., Carbajal-Sandoval, G., Ceballos-Liceaga, S. E., Arauz, A., & Valdes-Ferrer, S. I. (2020). Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clinical Imunology, 230(2021). https://doi.org/https://doi.org/10.1016/j.clim.2021.108818
Goddery, E. N., Fain, C. E., Lipovsky, C. G., Ayasoufi, K., Yokanovich, L. T., Malo, C. S., ... & Johnson, A. J. (2021). Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain. Frontiers in immunology, 12, 726421.
Grave, C., Boucheron, P., Rudant, J., Mikaeloff, Y., Tubert-Bitter, P., Escolano, S., Hocine, M. N., Coste, J., & Weill, A. (2020). Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study. Neurology, 94(20), E2168–E2179. https://doi.org/10.1212/WNL.0000000000009180
Greene, S. K., Rett, M., Weintraub, E. S., Li, L., Yin, R., Amato, A. A., Ho, D. T., Sheikh, S. I., Fireman, B. H., Daley, M. F., Belongia, E. A., Jacobsen, S. J., Baxter, R., Lieu, T. A., Kulldorff, M., Vellozzi, C., & Lee, G. M. (2012). Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009-2010. American Journal of Epidemiology, 175(11), 1100–1109. https://doi.org/10.1093/aje/kws195
Grohskopf, L. A., Ferdinands, J. M., Blanton, L. H., Broder, K. R., & Loehr, J. (2024). Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports, 73(5), 1–25. https://doi.org/10.15585/mmwr.rr7305a1
Ha, J., Park, S., Kang, H., Kyung, T., Kim, N., Kim, D. K., Kim, H., Bae, K., Song, M. C., Lee, K. J., Lee, E., Hwang, B. S., Youn, J., Seok, J. M., & Park, K. (2023). Real-world data on the incidence and risk of Guillain–Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study. Scientific Reports, 13(1), 1–9. https://doi.org/10.1038/s41598-023-30940-1
Haber, P., Sejvar, J., Mikaeloff, Y., & DeStefano, F. (2009). Vaccines and Guillain-Barre Syndrome syndrome. Drug Safety, 32(4), 309–323. https://doi.org/10.1007/978-1-4614-7438-8_17
Hanson, K. E., Goddard, K., Lewis, N., Fireman, B., Myers, T. R., Bakshi, N., Weintraub, E., Donahue, J. G., Nelson, J. C., Xu, S., Glanz, J. M., Williams, J. T. B., Alpern, J. D., & Klein, N. P. (2022). Incidence of Guillain-Barré syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Network Open, 5(4), E228879. https://doi.org/10.1001/jamanetworkopen.2022.8879
Hasan, T., Khan, M., Khan, F., & Hamza, G. (2021). Case of Guillain-Barré syndrome following COVID-19 vaccine. BMJ Case Reports, 14(6), 1–4. https://doi.org/10.1136/bcr-2021-243629
Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., Su, J. R., Licata, C., Rosenblum, H. G., Myers, T. R., Shimabukuro, T. T., & Shay, D. K. (2021). COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021. MMWR. Morbidity and Mortality Weekly Report, 70(31), 1053–1058. https://doi.org/10.15585/MMWR.MM7031E1
Hauser, S. L., & Josephon, S. A. (2013). Harrison’s Neurology in Clinical Medicine. In D. L. Longo, D. L. Kasper, J. L. Jameson, A. S. Fauci, S. L. Hauser, & J. Loscalzo (Eds.), Encyclopedia of the Neurological Sciences (3rd ed.). McGraw-Hill Education.
Hawken, S., Kwong, J. C., Deeks, S. L., Crowcroft, N. S., McGeer, A. J., Ducharme, R., Campitelli, M. A., Coyle, D., & Wilson, K. (2015). Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome. Emerging Infectious Diseases, 21(2), 224–231. https://doi.org/10.3201/eid2102.131879
Hilts, A., Schreiber, A., & Singh, A. (2022). A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré syndrome. American Journal of Case Reports, 23, 1–4. https://doi.org/10.12659/AJCR.936896
Hunaifi, I., Krisna, I. G. L., Fitriantoro, S., Suryani, D., Prita, B., Wardi, R., Noururrifqiyati, S., & Putri, J. (2024). Education About Guillain Barre Syndrome for Cadres in The Working Area of Karang Taliwang Community Health Center and Tanjung Karang Community Health Center. Jurnal Abdi Insani, 11, 3041–3047.
Iqbal, S., Li, R., Gargiullo, P., & Vellozzi, C. (2015). Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage. Vaccine, 33(17), 2045–2049. https://doi.org/10.1016/j.vaccine.2015.02.064
Jaffry, M., Mostafa, F., Mandava, K., Rosario, S., Jagarlamudi, Y., Jaffry, K., Kornitzer, J., & Jedidi, K. (2022). No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study. Vaccine, 40(2022), 5791–5797.
Jeong, Y. D., Park, S., Lee, S., Jang, W., Park, J., Lee, K., Lee, J., Kang, J., Udeh, R., Rahmati, M., Yeo, S. G., Smith, L., Lee, H., & Yon, D. K. (2024). Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023. Scientific Reports, 14(1), 24561. https://doi.org/10.1038/s41598-024-74729-2
Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., Seliger, C., Lorenz, H. M., Nagel, S., Wildemann, B., Bendszus, M., Wick, W., & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. European Journal of Neurology, 29(2), 555–563. https://doi.org/10.1111/ene.15147
Keh, R. Y. S., Scanlon, S., Datta-Nemdharry, P., Donegan, K., Cavanagh, S., Foster, M., Skelland, D., Palmer, J., Machado, P. M., Keddie, S., Carr, A. S., & Lunn, M. P. (2023). COVID-19 vaccination and Guillain-Barr syndrome: analyses using the National Immunoglobulin Database. Brain, 146(2), 739–748. https://doi.org/10.1093/brain/awac067
Khan, S. A., Das, P. R., Nahar, Z., & Dewan, S. M. R. (2024). An updated review on Guillain-Barré syndrome: Challenges in infection prevention and control in low- and middle-income countries. SAGE Open Medicine, 12. https://doi.org/10.1177/20503121241239538
Koike, H., Chiba, A., & Katsuno, M. (2021). Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review. Neurology and Therapy, 10(2), 523–537. https://doi.org/10.1007/s40120-021-00261-4
Kwong, J. C., Vasa, P. P., Campitelli, M. A., Hawken, S., Wilson, K., Rosella, L. C., Stukel, T. A., Crowcroft, N. S., McGeer, A. J., Zinman, L., & Deeks, S. L. (2013). Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: A self-controlled study. The Lancet Infectious Diseases, 13(9), 769–776. https://doi.org/10.1016/S1473-3099(13)70104-X
Lee, H., Kang, H. Y., Jung, S. Y., & Lee, Y. M. (2020). Incidence of Guillain-Barré syndrome is not associated with influenza vaccination in the elderly. Vaccines, 8(3), 1–13. https://doi.org/10.3390/vaccines8030431
Lee, H. Y., & Lien, W. C. (2023). Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review. Human Vaccines and Immunotherapeutics, 19(1), 4–5. https://doi.org/10.1080/21645515.2023.2171231
Lehmann, H. C., Hartung, H. P., Kieseier, B. C., & Hughes, R. A. C. (2010). Guillain-Barré syndrome after exposure to influenza virus. The Lancet Infectious Diseases, 10(9), 643–651. https://doi.org/10.1016/S1473-3099(10)70140-7
Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., Bateman, K., Ferreira, M. L. B., Cornblath, D. R., van Doorn, P. A., Dourado, M. E., Hughes, R. A. C., Islam, B., Kusunoki, S., Pardo, C. A., Reisin, R., Sejvar, J. J., Shahrizaila, N., Soares, C., Umapathi, T., Wang, Y., Yiu, E. M., … Jacobs, B. C. (2019). Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology, 15(11), 671–683. https://doi.org/10.1038/s41582-019-0250-9
Levison, L. S., Thomsen, R. W., & Andersen, H. (2022). Guillain–Barré syndrome following influenza vaccination: A 15-year nationwide population-based case–control study. In European Journal of Neurology (Vol. 29, Issue 11, pp. 3389–3394). https://doi.org/10.1111/ene.15516
Li, J. Y., Chen, H., Dong, H. Q., Jia, J. P., & Yi, Y. (2024). Clinical features and treatment of acute motor axonal neuropathy. Chinese Journal of Contemporary Neurology and Neurosurgery, 15(12), 990–993. https://doi.org/10.3969/j.issn.1672-6731.2015.12.014
Liu, D. Y., Hollenbach, J. R., Gregorin, J. A., & Wynbrandt, J. H. (2020). A Case of Acute Motor Sensory Axonal Neuropathy: A Variant of Guillain-Barré syndrome, with Possible Syndrome of Irreversible Lithium-Effectuated Neurotoxicity. Case Reports in Medicine, 2020, 4–7. https://doi.org/10.1155/2020/4683507
Lukito, V., Mangunatmadja, I., Pudjiadi, A. H., & Puspandjono, T. M. (2016). Plasmaferesis Sebagai Terapi Sindrom Guillain-Barre Berat pada Anak. Sari Pediatri, 11(6), 448. https://doi.org/10.14238/sp11.6.2010.448-55
Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 Vaccine. Annals of Neurology, 90(2), 312–314. https://doi.org/10.1002/ana.26143
Miranda, S., Chaignot, C., Collin, C., Dray-Spira, R., Weill, A., & Zureik, M. (2017). Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2 million young girls in France. Vaccine, 35(36), 4761–4768. https://doi.org/10.1016/j.vaccine.2017.06.030
Nelson, K. E. (2012). Invited commentary: Influenza vaccine and Guillain-Barré syndrome-is there a risk? American Journal of Epidemiology, 175(11), 1129–1132. https://doi.org/10.1093/aje/kws194
Netto, A. B., Taly, A. B., Kulkarni, G. B., Umamaheswara Rao, G. S., & Rao, S. (2011). Mortality in mechanically ventilated patients of Guillain Barr Syndrome. Annals of Indian Academy of Neurology, 14(4), 262–266. https://doi.org/10.4103/0972-2327.91942
Noioso, C. M., Bevilacqua, L., Acerra, G. M., Della Valle, P., Serio, M., Vinciguerra, C., Piscosquito, G., Toriello, A., Barone, P., & Iovino, A. (2023). Miller Fisher syndrome: an updated narrative review. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1250774
Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., Fragkou, P. C., Papadopoulou, M., Moschovos, C., Michopoulos, I., Kokotis, P., Bakirtzis, C., Naska, A., Vassilakopoulos, T. I., Chroni, E., Tsiodras, S., & Tsivgoulis, G. (2021). Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. European Journal of Neurology, 28(10), 3517–3529. https://doi.org/10.1111/ene.14860
Park, Y. S., Lee, K. J., Kim, S. W., Kim, K. M., & Suh, B. C. (2017). Clinical features of post-vaccination Guillain-Barré syndrome (GBS) in Korea. Journal of Korean Medical Science, 32(7), 1154–1159. https://doi.org/10.3346/jkms.2017.32.7.1154
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., Hunt, D., Mei, X. W., Dixon, S., Zaccardi, F., Khunti, K., Watkinson, P., Coupland, C. A. C., Doidge, J., Harrison, D. A., Ravanan, R., Sheikh, A., Robertson, C., & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), 2144–2153. https://doi.org/10.1038/s41591-021-01556-7
Perez-Vilar, S., Wernecke, M., Arya, D., Lo, A. C., Lufkin, B., Hu, M., Chu, S., MaCurdy, T. E., Kelman, J., & Forshee, R. A. (2019). Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017–2018 season. Vaccine, 37(29), 3856–3865. https://doi.org/10.1016/j.vaccine.2019.05.041
Petráš, M., Lesná, I. K., Dáňová, J., & Čelko, A. M. (2020). Is an increased risk of developing guillain–barré syndrome associated with seasonal influenza vaccination? A systematic review and meta-analysis. Vaccines, 8(2), 1–11. https://doi.org/10.3390/vaccines8020150
Principi, N., & Esposito, S. (2020). Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes? Frontiers in Public Health, 8(July), 1–9. https://doi.org/10.3389/fpubh.2020.00361
Rajput, J., Rajput, P., Mohanty, E., & Saini, G. K. (2025). The impact of preceding infections on the clinical presentation and prognosis of Guillain-Barré syndrome: A focus on post-COVID-19 GBS. Brain Disorders, 17(February), 100196. https://doi.org/10.1016/j.dscb.2025.100196
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J. M. (2018). Molecular mimicry and autoimmunity. Journal of Autoimmunity, 95(September), 100–123. https://doi.org/10.1016/j.jaut.2018.10.012
Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., … Douoguih, M. (2021). Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. New England Journal of Medicine, 384(23), 2187–2201. https://doi.org/10.1056/nejmoa2101544
Salmon, D. A., Dudley, M. Z., & Carleton, B. C. (2020). Guillain-Barré syndrome following influenza vaccines affords opportunity to improve vaccine confidence. Journal of Infectious Diseases, 223(3), 355–358. https://doi.org/10.1093/infdis/jiaa544
Scendoni, R., Petrelli, C., Scaloni, G., & Logullo, F. O. (2021). Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine. Human Vaccines and Immunotherapeutics, 17(11), 4093–4096. https://doi.org/10.1080/21645515.2021.1954826
Schonberger, L. B., Hurwitz, E. S., Katona, P., Holman, R. C., & Bregman, D. J. (1981). Guillain‐Barré syndrome: Its epidemiology and associations with influenza vaccination. Annals of Neurology, 9(1 S), 31–38. https://doi.org/10.1002/ana.410090707
Soni, R., Heindl, S. E., Wiltshire, D. A., Vahora, I. S., & Khan, S. (2020). Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barré Syndrome and Influenza Vaccine – Up to Date Literature Review. Cureus, 12(9). https://doi.org/10.7759/cureus.10208
Sosa-Hernández, O., & Sánchez-Cardoza, S. (2022). Case report of Guillain-Barré syndrome after COVID BNT162b2 mRNA vaccine. Vacunas, 23(205), 68–70. https://doi.org/10.1016/j.vacun.2022.02.002
Souayah, N., Michas-Martin, P. A., Nasar, A., Krivitskaya, N., Yacoub, H. A., Khan, H., & Qureshi, A. I. (2011). Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine, 29(5), 886–889. https://doi.org/10.1016/j.vaccine.2010.09.020
Stillo, M., Carrillo Santisteve, P., & Lopalco, P. L. (2015). Safety of human papillomavirus vaccines: A review. Expert Opinion on Drug Safety, 14(5), 697–712. https://doi.org/10.1517/14740338.2015.1013532
Theresia. (2017). Laporan Kasus Penanganan Sindrom Guillan-Barre Dengan Terapi Plasmaferesis. Nursing Current, 5(2), 8–19.
Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401–4402. https://doi.org/10.1007/s10072-021-05523-5
Vellozzi, C., Iqbal, S., & Broder, K. (2014). Guillain-Barré syndrome, influenza, and influenza vaccination: The epidemiologic evidence. Clinical Infectious Diseases, 58(8), 1149–1155. https://doi.org/10.1093/cid/ciu005
Wajih Ullah, M., Qaseem, A., & Amray, A. (2018). Post Vaccination Guillain Barre Syndrome: A Case Report. Cureus, 10(4), 6–8. https://doi.org/10.7759/cureus.2511
Wan, M. M., Lee, A., Kapadia, R., & Hahn, C. (2022). Case Series of Guillain-Barré syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine. Neurology: Clinical Practice, 12(2), 149–153. https://doi.org/10.1212/CPJ.0000000000001148
WHO. (2023). Guillain–Barré syndrome. Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/guillain-barré-syndrome
Willison, H. J. (2018). Anti-ganglioside antibodies in peripheral nerve pathology. Methods in Molecular Biology, 1804, 173–188. https://doi.org/10.1007/978-1-4939-8552-4_7
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain-Barré syndrome. The Lancet, 388(10045), 717–727. https://doi.org/10.1016/S0140-6736(16)00339-1
Yen, C. C., Wei, K. C., Wang, W. H., Huang, Y. T., & Chang, Y. C. (2022). Risk of Guillain-Barré syndrome among Older Adults Receiving Influenza Vaccine in Taiwan. JAMA Network Open, 5(9), E2232571. https://doi.org/10.1001/jamanetworkopen.2022.32571
Yi, S. W., Lee, J. H., Hong, J. M., Choi, Y. C., & Park, H. J. (2022). Incidence, Disability, and Mortality in Patients With Guillain-Barré syndrome in Korea: A Nationwide Population-Based Study. Journal of Clinical Neurology (Korea), 18(1), 48–58. https://doi.org/10.3988/jcn.2022.18.1.48
Yu, M., Nie, S., Qiao, Y., & Ma, Y. (2023). Guillain-Barre syndrome following COVID-19 vaccines: A review of literature. Frontiers in Immunology, 14(February). https://doi.org/10.3389/fimmu.2023.1078197
License
Copyright (c) 2025 Tabitha Afifah Febianisa, Lalu Gde Gilang Alid Hadinata, Ilsa Hunaifi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
